Skip to content

A clinical trial to study the effect of two drugs kinshuk gel and thrombophob gel in patients with thrombophlebitis

Evaluation Of comparative efficacy of newly developed Kinshuk gel versus active control compound (Heparin Sodium plus Benzyl Nicotinate in the management of Thrombophlebitis (Sira Granthi Vikar) (RCT) - NILL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084217
Enrollment
30
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified Health Condition 2: I808- Phlebitis and thrombophlebitis ofother sites

Interventions

None listed

Sponsors

Dr Mansi Nakum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient willing with written informed consent as per Helsinki declaration. 2) Age group of 17 to 70 years. 3) Patients with clinical features of thrombophlebitis (swelling , redness , pain , warmth) 4) Patients irrespective of gender, occupation and economic status.

Exclusion criteria

Exclusion criteria: 1) Phlebitis caused by Malignancy, Septicemia, deep vein thrombosis or with pus formation 2) Uncontrolled and insulin dependent Diabetes Mellitus, Uncontrolled Hypertension , Tuberculosis, Carcinoma Endocrine Disorders and Kidney or hepatic disorder. 3) Sites of thrombophlebitis – sensitive places like : genitals, eye lids, lips Pregnant and lactating females.

Design outcomes

Primary

MeasureTime frame
Kinshuk gel is as equally efficacious as Standard Compound in the management of Thrombophlebitis sira granthi vikarTimepoint: 1 week

Secondary

MeasureTime frame
Decreases swelling pain tendernessTimepoint: Decreases swelling pain tenderness;Decrease pain swelling tenderness clot dissolveTimepoint: 7days

Countries

India

Contacts

Public ContactDr Devyani Dasar

Mahatma gandhi ayurved college salod wardha datta meghe higher education and research center

devyanidasar06@gmail.com9503630392

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026